17041618

Source:http://linkedlifedata.com/resource/pubmed/id/17041618

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027342, umls-concept:C0079773
pubmed:issue	11
pubmed:dateCreated	2006-10-16
pubmed:abstractText	The impact of immunotherapy on the natural progression of cutaneous T-cell lymphoma (CTCL), particularly the mycosis fungoides and Sézary syndrome variants, has been based on our evolving understanding of the disease's immunobiology.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17041618-16960554
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0426720
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1523-1747
pubmed:author	pubmed-author:LessinStuart RSR
pubmed:issnType	Electronic
pubmed:volume	126
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2368-9
pubmed:meshHeading	pubmed-meshheading:17041618-Animals, pubmed-meshheading:17041618-Disease Progression, pubmed-meshheading:17041618-Humans, pubmed-meshheading:17041618-Immunotherapy, pubmed-meshheading:17041618-Lymphoma, T-Cell, Cutaneous, pubmed-meshheading:17041618-Mice, pubmed-meshheading:17041618-Mycosis Fungoides, pubmed-meshheading:17041618-Sezary Syndrome, pubmed-meshheading:17041618-Skin Neoplasms
pubmed:year	2006
pubmed:articleTitle	A new nail in the CTCL coffin.
pubmed:affiliation	Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. stuart.lessin@fccc.edu
pubmed:publicationType	Journal Article, Comment